In little more than a decade, the use of carotid stenting for prevention of cerebrovascular events has grown greatly. In 1998, roughly 0.1 per 1000 Medicare beneficiaries per year received a carotid stenting procedure. By 2007, that number had increased to 0.6 procedures per 1000 beneficiaries per year.1 Overall rates of carotid revascularization decreased during this period, suggesting that carotid stenting was substituted for carotid endarterectomy (CEA). Even more dramatically, coincident with widespread Medicare coverage of carotid stenting beginning in October 2004, there was a quadrupling of procedures in 2 years.2 From 2004 to 2006, the number of stenting procedures increased from a mean of 266 per month to 1015 per month. Furthermore, prior to widespread Medicare coverage, 82% of carotid stent recipients had a diagnosis of prior transient ischemic attack (TIA) (3756 of 4590), while in the era after widespread coverage only 23% (1216 of 5354) had a diagnosis of prior TIA. This change suggests an increased rate of implant procedures in asymptomatic patients. In fact, some authors estimate that 70% to 90%3 of carotid stents are now being placed in asymptomatic patients. We believe the increase in carotid stenting procedures at the expense of CEA, as well as the number of asymptomatic patients treated, to be concerning for several reasons.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.